Public-domain · open source
OpenJurist
← 431 F. Supp. 2d 566 - Ames v. Apothecon, Inc.

431 F. Supp. 2d 566 - Ames v. Apothecon, Inc.’s Empirical Analysis

2006

Citation profile

9
cited by 9 later decisions
1
states following
August 2016
most recently cited

6 district · 2 state decisions

Relationships

Relies on Anderson v. Liberty Lobby, Inc. · Celotex Corporation v. Catrett H · Felty v. Graves-Humphreys Co. · Pulliam Investment Co. v. Cameo Properties · Nolan v. Dillon

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 9 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “[A] product defect claim based on insufficient warnings cannot survive summary judgment if stronger warnings would not have altered the conduct of the prescribing physician.”) (alteration in original) (quoting Motus v. Pfizer Inc., 358 F.3d 659, 661 (9th Cir.2004) (”
    1 later decision quote this exact passage
  2. “One might prefer to have SJS/TEN listed in the Warnings section, but the present structure cannot be said to be unreasonable merely because it reguires the reader to make a cross-reference.”
    1 later decision quote this exact passage

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.